Edition:
United Kingdom

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

78.57USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$78.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
159,375
52-wk High
$102.37
52-wk Low
$45.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 5.11 -2.041
Mar '19 0.73 -1.982
FY 2018 Dec '18 1.03 -1.826
Sep '18 1.10 -1.656
Jun '18 41.44 -0.617
Mar '18 0.95 -1.294
FY 2017 Dec '17 1.63 -1.225
Sep '17 8.07 -0.964
Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 9 2.44 6.50 0.00 31.26
Quarter Ending Dec-19 9 2.90 6.27 0.00 21.26
Year Ending Dec-19 9 10.70 20.00 4.00 24.66
Year Ending Dec-20 11 33.63 65.57 11.60 77.83
Earnings (per share)
Quarter Ending Sep-19 11 -2.19 -1.93 -2.46 -1.13
Quarter Ending Dec-19 11 -2.31 -2.00 -2.70 -1.30
Year Ending Dec-19 11 -8.53 -7.95 -9.24 -6.83
Year Ending Dec-20 11 -8.96 -7.64 -10.24 -6.28
LT Growth Rate (%) 1 22.27 22.27 22.27 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.38 32.67
P/E High - Last 5 Yrs. -- 147.67 47.29
P/E Low - Last 5 Yrs. -- 47.98 23.87
Beta -- 1.09 0.89
Price to Sales (TTM) 101.33 49.45 7.91
Price to Book (MRQ) 6.92 10.14 5.38
Price to Tangible Book (MRQ) 6.93 13.74 6.71
Price to Cash Flow (TTM) -- 55.94 24.37
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -16.63 205.61 12.23
Sales (TTM) vs TTM 1 Yr. Ago 16.37 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.79 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.91 75.23 42.99
EPS (TTM) vs TTM 1 Yr. Ago -32.61 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 13.07 3.59 3.03
LT Debt to Equity (MRQ) 0.18 18.57 10.20
Total Debt to Equity (MRQ) 0.71 31.18 14.55
Interest Coverage (TTM) -103.52 -44.60 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.08 52.23
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -387.82 -- --
EBITD - 5 Yr. Avg -- -110.38 13.13
Operating Margin (TTM) -394.04 -184.16 6.90
Operating Margin - 5 Yr. Avg. -- -126.82 8.94
Pre-Tax Margin (TTM) -388.91 -174.91 6.11
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 9.23
Net Profit Margin (TTM) -388.91 -181.60 2.74
Net Profit Margin - 5 Yr. Avg. -- -136.95 5.60
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 241,330 7,668,822 887,145,550
Net Income/Employee (TTM) -938,547 533,853 101,828,525
Receivable Turnover (TTM) 7.96 6.28 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.08 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.52 6.40 11.17
Return on Assets - 5 Yr. Avg. -- 5.49 12.34
Return on Investment (TTM) -34.88 8.94 14.48
Return on Investment - 5 Yr. Avg. -- 6.81 16.02
Return on Equity (TTM) -40.89 10.07 15.78
Return on Equity - 5 Yr. Avg. -- 8.38 17.01
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 26.74 22.37 99 99
13 Week 24.13 18.08 99 95
26 Week 48.03 36.78 99 97
52 Week 147.42 109.71 99 71
YTD 136.22 107.45 99 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 307
Total Shares Held: 51,818,844
3 Mo. Net Change: 2,949,269
# New Positions: 63
# Closed Positions: 35
# Increased Positions: 192
# Reduced Positions: 97
# Net Buyers: 95
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.